Pharmacovigilance in developing countries (part I): importance and challenges

Area of Science:

• Pharmacovigilance and Global Drug Safety
• Public Health Policy in Developing Nations

Background:

• The thalidomide disaster catalyzed pharmacovigilance development in developed countries.
• Drug safety monitoring systems are underdeveloped in many developing countries.
• There is a growing need for post-marketing drug surveillance in developing nations.

Purpose of the Study:

• To analyze the obstacles to establishing effective pharmacovigilance systems in developing countries.
• To highlight the importance of drug safety monitoring in resource-limited settings.

Main Methods:

• Literature review and analysis of existing pharmacovigilance frameworks.
• Examination of challenges specific to developing country contexts.

Main Results:

• Identified key barriers including resource limitations, lack of trained personnel, and inadequate regulatory frameworks.
• Highlighted the disparity in pharmacovigilance infrastructure between developed and developing nations.

Conclusions:

• Addressing the identified barriers is crucial for improving drug safety in developing countries.
• Strengthening pharmacovigilance is essential for protecting public health globally.